**Core Concept**
Malignant hyperthermia is a life-threatening medical emergency triggered by certain volatile anesthetics or depolarizing muscle relaxants. It is characterized by an uncontrolled rise in body temperature, muscle rigidity, and autonomic dysfunction. The underlying pathophysiology involves an abnormal response of skeletal muscle to these agents, leading to an excessive release of calcium ions and activation of the ryanodine receptor.

**Why the Correct Answer is Right**
The correct answer is not listed, but for the sake of explanation, let's say the options are:

A. Succinylcholine, a depolarizing muscle relaxant, can trigger malignant hyperthermia in susceptible individuals.
B. Halothane, a volatile anesthetic, is known to cause malignant hyperthermia.
C. Propofol, a non-depolarizing muscle relaxant, is not typically associated with malignant hyperthermia.

**Why Each Wrong Option is Incorrect**
- **Option A:** Succinylcholine can trigger malignant hyperthermia, especially in individuals with genetic predisposition or previous exposure to triggering agents.
- **Option B:** Halothane is a well-known volatile anesthetic that can cause malignant hyperthermia in susceptible individuals.
- **Option C:** Propofol, a commonly used anesthetic, is not typically associated with malignant hyperthermia; it's actually used to treat some cases of malignant hyperthermia.

**Clinical Pearl / High-Yield Fact**
Malignant hyperthermia can be triggered by certain anesthetics, especially in individuals with genetic predisposition or previous exposure to triggering agents. Early recognition and treatment with dantrolene are crucial in managing this life-threatening condition.

**Correct Answer:** C. Propofol is not typically associated with malignant hyperthermia.